CNO Financial Group, Inc. (CNO) Form 10-Q — Nov 5, 2026
CNO Financial Group reported Q3 2026 net income of $161.1 million ($1.71 diluted EPS), up sharply from $23.1 million ($0.24) a year earlier, with nine-month net income of $324.7 million versus $136.4 million. Net operating income (non-GAAP) rose 41% year over year to $179.1 million in Q3, boosted by a $36.0 million net favorable impact from the comprehensive annual actuarial review, 13% growth in total net investment income, and continued strength across annuity and life margins. Return on equity improved to 16.4% from 12.5%.
Key figures
- Eps
- 3.41
- Revenue
- 3400800000
- Net Income
- 324700000
- Revenue Yoy
- Q3 revenue $1,086.0M vs $1,188.7M prior year; nine-month revenue $3,400.8M vs $3,344.3M
- Shares Outstanding
- 91705509
- Roe
- 16.4%
- Federal nols
- 836.1M
- Fhlb borrowings
- 3.2B
- Total investments
- 30,042.1M
- Q3 2025 diluted eps
- 0.24
- Q3 2026 diluted eps
- 1.71
- Buybacks nine months
- 3.8M shares for $180.0M
- Valuation allowance dta
- 22.1M
- Q3 insurance product margin
- 333.0M
- Dividend per share quarterly
- 0.18
- Q3 2025 net operating income
- 127.2M
- Q3 2026 net operating income
- 179.1M
- Remaining repurchase authority
- 240.4M
- Operating roe excl significant items
- 14.1%
- Actuarial review net favorable impact
- 36.0M
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.